{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:11:43Z","timestamp":1781626303348,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T00:00:00Z","timestamp":1304380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s12640-011-9245-z","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T18:38:01Z","timestamp":1304361481000},"page":"321-328","source":"Crossref","is-referenced-by-count":26,"title":["Idebenone Induces Apoptotic Cell Death in the Human Dopaminergic Neuroblastoma SHSY-5Y Cells"],"prefix":"10.1007","volume":"20","author":[{"given":"Kwok-Keung","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. D.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"key":"9245_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2002-34494","volume":"33","author":"R Artuch","year":"2002","unstructured":"Artuch R, Aracil A, Mas A et al (2002) Friedreich\u2019s ataxia: idebenone treatment in early stage patients. Neuropediatrics 33:190\u2013193","journal-title":"Neuropediatrics"},{"key":"9245_CR2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","volume":"6","author":"NA Di Prospero","year":"2007","unstructured":"Di Prospero NA, Baker A, Jeffries N et al (2007a) Neurological effects of high-dose idebenone in patients with Friedreich\u2019s ataxia: a randomised, placebo-controlled trial. Lancet Neurol 6:878\u2013886","journal-title":"Lancet Neurol"},{"key":"9245_CR3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.64.6.803","volume":"64","author":"NA Di Prospero","year":"2007","unstructured":"Di Prospero NA, Sumner CJ, Penzak SR et al (2007b) Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia. Arch Neurol 64:803\u2013808","journal-title":"Arch Neurol"},{"key":"9245_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00002512-199405020-00007","volume":"5","author":"JC Gillis","year":"1994","unstructured":"Gillis JC, Benefield P, McTavish D (1994) Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders. Drugs Aging 5:133\u2013152","journal-title":"Drugs Aging"},{"key":"9245_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/tx970136j","volume":"11","author":"A Mordente","year":"1998","unstructured":"Mordente A, Martorana GE, Minotti G (1998) Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone). Chem Res Toxicol 11:54\u201363","journal-title":"Chem Res Toxicol"},{"key":"9245_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.410420222","volume":"42","author":"J Priller","year":"1997","unstructured":"Priller J, Scherzer CR, Faber PW (1997) Frataxin gene of Friedreich\u2019s ataxia is targeted to mitochondria. Ann Neurol 42:265\u2013269","journal-title":"Ann Neurol"},{"key":"9245_CR7","doi-asserted-by":"crossref","unstructured":"Strauss W (1999) Preparation of genomic DNA from mammalian tissue. Curr Protoc Neurosci A.1H.1\u2013A.1H.3","DOI":"10.1002\/0471142301.nsa01hs06"},{"key":"9245_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0167-4943(89)90011-3","volume":"8","author":"M Suno","year":"1989","unstructured":"Suno M, Nagaoka A (1989) Inhibition of brain mitochondrial swelling by idebenone. Arch Gerontol Geriatr 8:299\u2013305","journal-title":"Arch Gerontol Geriatr"},{"key":"9245_CR9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jnr.10309","volume":"69","author":"KK Tai","year":"2002","unstructured":"Tai KK, Truong DD (2002) Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson\u2019s disease. J Neurosci Res 69:559\u2013566","journal-title":"J Neurosci Res"},{"key":"9245_CR10","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1073\/pnas.061449498","volume":"98","author":"KK Tai","year":"2001","unstructured":"Tai KK, Blondelle SE, Ostresh JM (2001) An N-methyl-d-aspartate receptor channel blocker with neuroprotective activity. Proc Natl Acad Sci 98:3519\u20133524","journal-title":"Proc Natl Acad Sci"},{"key":"9245_CR11","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/sj.cdd.4401804","volume":"13","author":"CX Wang","year":"2006","unstructured":"Wang CX, Song JH, Song DK (2006) Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death Differ 13:1203\u20131212","journal-title":"Cell Death Differ"},{"key":"9245_CR12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1096\/fj.02-0712fje","volume":"17","author":"O Weinreb","year":"2003","unstructured":"Weinreb O, Mandel S, Youdim MB (2003) cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. Faseb J 17:935\u2013937","journal-title":"Faseb J"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-011-9245-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-011-9245-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-011-9245-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T13:09:19Z","timestamp":1712408959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-011-9245-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["9245"],"URL":"https:\/\/doi.org\/10.1007\/s12640-011-9245-z","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}